Search

Your search keyword '"Claire-Anne Siegrist"' showing total 337 results

Search Constraints

Start Over You searched for: Author "Claire-Anne Siegrist" Remove constraint Author: "Claire-Anne Siegrist"
337 results on '"Claire-Anne Siegrist"'

Search Results

1. Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America

2. Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP

3. Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts

4. Influence of circadian clocks on adaptive immunity and vaccination responses

5. Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

6. C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates

7. Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19

8. Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study

9. Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis

10. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity

11. Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?

12. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series

13. A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner

14. Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis

15. Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV

16. Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization

17. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

19. Maternal Antibodies Inhibit Neonatal and Infant Responses to Vaccination by Shaping the Early-Life B Cell Repertoire within Germinal Centers

20. Neonatal T Follicular Helper Cells Are Lodged in a Pre-T Follicular Helper Stage Favoring Innate Over Adaptive Germinal Center Responses

21. Site-Specific DC Surface Signatures Influence CD4+ T Cell Co-stimulation and Lung-Homing

22. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation

23. Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine

24. The 2014–2015 Ebola outbreak in West Africa: Hands On

25. Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein 180L Single-Nucleotide Polymorphism Is Associated With Susceptibility to Recurrent Pneumococcal Lower Respiratory Tract Infections in Children

26. Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan

27. AS03- and MF59-Adjuvanted Influenza Vaccines in Children

28. Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey.

29. Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

30. Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases

31. Diagnosis of whooping cough in Switzerland: differentiating Bordetella pertussis from Bordetella holmesii by polymerase chain reaction.

32. Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life.

33. Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine.

34. Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients

36. Impaired antibody response causes persistence of prototypic T cell-contained virus.

37. A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells.

38. Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant.

39. Influence of Timing of Maternal Pertussis Immunization on the Avidity of Transferred Antibodies in Term and Preterm Neonates

40. Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab

41. Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence

43. Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel Disease

44. Transcriptomic signatures induced by the Ebola virus vaccine rVSV Delta G-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study

45. Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants

46. Sars-CoV2- infection as a trigger of humoral response against apolipoprotein A-1

47. SARS‐CoV‐2 infection as a trigger of humoral response against apolipoprotein A‐1

48. Patients treated with anti-CD20 therapy can mount robust T cell responses to mRNA-based COVID-19 vaccines

49. Missed vaccinations and critical care admission: all you may wish to know or rediscover—a narrative review

50. Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study

Catalog

Books, media, physical & digital resources